Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537413) titled 'Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia' on April 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Maryland, Baltimore

Condition: Community Acquired Pneumonia (CAP)

Intervention: Drug: Ceftriaxone 1 gram daily

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 1, 2026

Target Sample Size: 430

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07537413 ...